New drug combo targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This early-phase study tests a new drug called ADU-1805, alone or with another cancer drug (pembrolizumab), in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and how the drug moves through the body. About 130 p…
Phase: PHASE1 • Sponsor: Sairopa B.V. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC